#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute lymphocytic leukaemia recurrent Synovial sarcoma metastatic Hypoparathyroidism Marginal zone lymphoma Renal transplant Cytokine release syndrome Vulval cancer recurrent Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Type IIa hyperlipidaemia Cardiomyopathy Angiosarcoma non-metastatic KBG syndrome Piriformis syndrome Noonan syndrome Hyperinsulinaemic hypoglycaemia More trials…

    Learn about Rare Diseases

    Small intestine leiomyosarcoma – Trials in Disease Paroxysmal nocturnal haemoglobinuria – Life with Disease Acquired haemophilia – Life with Disease Mucopolysaccharidosis – Treatment Cystic fibrosis lung – Life with Disease Hyperoxaluria – Diagnostics Mucopolysaccharidosis III – Basic Information Lymphangiosarcoma Familial haemophagocytic lymphohistiocytosis – Trials in Disease Haemophilia A without inhibitors – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Iodixanol Tulisokibart Zopiclone Ravulizumab Alizapride Bi 3032950 Sulodexide Octreotide Pomalidomide BUMETANIDE CLESROVIMAB Bemnifosbuvir Hemisulfate Vutrisiran Monalizumab Gd2Il18Cart Amg 193 Diclofenac Diethylamine Sym023 Human Coagulation Factor Ii Cefotaxime Sodium More therapies…

    Learn about Your Condition

    Lung adenocarcinoma stage III Diabetic retinopathy Developmental hip dysplasia Rectal cancer recurrent Bladder cancer Rectal cancer stage II Facial paresis Hereditary angioedema Lung transplant Cardiac failure congestive Head and neck cancer stage III Delayed graft function Rectal cancer stage III Skin disorder Haemorrhage prophylaxis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mesothelioma

  • Study of Long-term Safety of Tazemetostat in Patients Who Previously Participated in Tazemetostat Clinical Trials

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Extraskeletal myxoid chondrosarcoma
    • Follicle centre lymphoma diffuse small cell lymphoma
    • Limb reduction defect
    Investigated Drugs:
    • Tazemetostat
    France Poland

  • Study on Calcium Folinate to Reduce Pemetrexed Side Effects in Patients with Non-Small Cell Lung Cancer, Mesothelioma, or Thymoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Calcium Folinate
    The Netherlands

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!